HIF1A and diabetes mellitus: In addition to increasing bone mass and reducing blood glucose levels, this study revealed that activating the HIF-1α pathway by specifically knocking out Vhl in osteoblasts partially alleviated the symptoms of streptozotocin (STZ)-induced type 1 diabetes mellitus (T1DM).